#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Emphysema Myelin oligodendrocyte glycoprotein antibody-associated disease Cardiac arrest Cognitive disorder Lymphangioma Neuroendocrine cell hyperplasia of infancy Breast angiosarcoma metastatic Advanced systemic mastocytosis Paraganglion neoplasm B-cell small lymphocytic lymphoma Corneal neovascularisation Cerebral arteriovenous malformation haemorrhagic Medulloblastoma recurrent Non-small cell lung cancer recurrent Graft versus host disease More trials…

    Learn about Rare Diseases

    Osteosarcoma – Basic Information Methylmalonic acidaemia – Treatment Alagille syndrome – Diagnostics Cystic fibrosis lung – Basic Information Alport’s syndrome – Diagnostics Isodicentric chromosome 15 syndrome – Basic Information Systemic mastocytosis – Treatment Short-bowel syndrome Richter’s syndrome – Trials in Disease Hereditary ataxia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Io102 Hydrochloride Cx-039776 Adg126 Pyridoxine Hydrochloride Bay 3283142 RLY-2608 Cx-037231 Zolbetuximab Mva-209-Fsp-B3 Icatibant Efzofitimod Montelukast Acetylcysteine Amide Vorinostat Etifoxine Hydrochloride Tamoxifen Citrate Terbinafine Hydrochloride Bms-986449-03 Olorofim Dapagliflozin Propanediol More therapies…

    Learn about Your Condition

    Anxiety disorder Kearns-Sayre syndrome Hyperoxaluria Aplasia pure red cell Stevens-Johnson syndrome Nephrogenic anaemia Epiphysiolysis Malignant lymphoid neoplasm Angiosarcoma metastatic Underweight Graft versus host disease Sarcoidosis Neuroendocrine carcinoma Arteriospasm coronary Renal failure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Betamethasone Sodium Phosphate and Drug Combination for Pregnant Women with Preterm Premature Rupture of Membranes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Preterm premature rupture of membranes
    Investigated Drugs:
    • Benzathine Benzylpenicillin
    • BENZYLPENICILLIN POTASSIUM
    • BENZYLPENICILLIN PROCAINE
    Czechia

  • Study Comparing Belantamab Mafodotin with Lenalidomide and Dexamethasone to Daratumumab with Lenalidomide and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Belantamab Mafodotin
    • Dexamethasone Ph. Eur.
    • Daratumumab
    Austria Belgium Czechia France Germany Greece +5

  • Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Previously Used Biologic Treatments

    Recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Jnj-77242113
    Bulgaria Czechia Denmark Germany Hungary Italy +3

  • Study of Patritumab Deruxtecan and Pembrolizumab for Patients with High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Human epidermal growth factor receptor negative
    • Triple negative breast cancer
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Patritumab Deruxtecan
    • Epirubicin Hydrochloride
    • Capecitabine
    Spain

  • Study of dexamethasone effectiveness in reducing complications and mortality in patients with severe burns

    Recruiting

    3 1 1
    Investigated Diseases:
    • Thermal burn
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Sodium Chloride
    France

  • Study on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Ivosidenib
    • Azacitidine
    • Venetoclax
    Austria Belgium Denmark Estonia Finland France +8
Previous Page
1 … 226 227 228 229 230 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!